Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolus (EOLS) Other Operating Expenses (2018 - 2025)

Historic Other Operating Expenses for Evolus (EOLS) over the last 8 years, with Q3 2025 value amounting to $107000.0.

  • Evolus' Other Operating Expenses rose 10440.69% to $107000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $305000.0, marking a year-over-year increase of 10644.0%. This contributed to the annual value of -$7.2 million for FY2024, which is 6856.94% down from last year.
  • According to the latest figures from Q3 2025, Evolus' Other Operating Expenses is $107000.0, which was up 10440.69% from $3.9 million recorded in Q2 2025.
  • Evolus' Other Operating Expenses' 5-year high stood at $25.5 million during Q1 2021, with a 5-year trough of -$2.4 million in Q3 2024.
  • Over the past 5 years, Evolus' median Other Operating Expenses value was -$1.5 million (recorded in 2022), while the average stood at $411166.7.
  • In the last 5 years, Evolus' Other Operating Expenses plummeted by 27885.71% in 2024 and then surged by 34386.29% in 2025.
  • Over the past 5 years, Evolus' Other Operating Expenses (Quarter) stood at -$1.4 million in 2021, then fell by 29.21% to -$1.8 million in 2022, then skyrocketed by 148.37% to $875000.0 in 2023, then tumbled by 278.86% to -$1.6 million in 2024, then soared by 106.84% to $107000.0 in 2025.
  • Its last three reported values are $107000.0 in Q3 2025, $3.9 million for Q2 2025, and -$2.2 million during Q1 2025.